195 related articles for article (PubMed ID: 16268418)
1. Stepwise minimization of the immunosuppressive therapy in pediatric liver transplantation. A conceptual approach towards operational tolerance.
Reding R; Gras J; Bourdeaux C; Wieers G; Truong QD; Latinne D; Sokal E; Janssen M; Lerut J; Otte JB; de Ville de Goyet J
Acta Gastroenterol Belg; 2005; 68(3):320-2. PubMed ID: 16268418
[TBL] [Abstract][Full Text] [Related]
2. Towards minimizing immunosuppression in pediatric liver transplant recipients.
Turmelle YP; Nadler ML; Anderson CD; Doyle MB; Lowell JA; Shepherd RW
Pediatr Transplant; 2009 Aug; 13(5):553-9. PubMed ID: 19067920
[TBL] [Abstract][Full Text] [Related]
3. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
4. Hot-topic debate on tolerance: immunosuppression withdrawal.
Sánchez-Fueyo A
Liver Transpl; 2011 Nov; 17 Suppl 3():S69-73. PubMed ID: 21850680
[TBL] [Abstract][Full Text] [Related]
5. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
6. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.
Feng S; Ekong UD; Lobritto SJ; Demetris AJ; Roberts JP; Rosenthal P; Alonso EM; Philogene MC; Ikle D; Poole KM; Bridges ND; Turka LA; Tchao NK
JAMA; 2012 Jan; 307(3):283-93. PubMed ID: 22253395
[TBL] [Abstract][Full Text] [Related]
7. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
8. Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients.
Kerkar N; Morotti RA; Iyer K; Arnon R; Miloh T; Sturdevant M; Suchy F; Florman S; Emre S
Clin Transplant; 2011; 25(6):E584-91. PubMed ID: 21919961
[TBL] [Abstract][Full Text] [Related]
9. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
10. Use of antilymphocyte induction therapy in liver transplantation.
Wall WJ
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019
[TBL] [Abstract][Full Text] [Related]
11. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
12. Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea.
Lee JH; Lee SK; Lee HJ; Seo JM; Joh JW; Kim SJ; Kwon CH; Choe YH
Yonsei Med J; 2009 Dec; 50(6):784-8. PubMed ID: 20046418
[TBL] [Abstract][Full Text] [Related]
13.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
14. Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease.
Weiner C; Weintraub L; Wistinghausen B; Tomaino J; Arnon R; Kerkar N; Miloh T
Pediatr Transplant; 2012 Aug; 16(5):458-64. PubMed ID: 22554096
[TBL] [Abstract][Full Text] [Related]
15. Operational tolerance: past lessons and future prospects.
Levitsky J
Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
17. Outcomes after complete immunosuppression withdrawal in liver transplant recipients: rejection-free graft tolerance or late acute rejection?
Yoshida EM; Chung SW
Can J Gastroenterol; 1998 Sep; 12(6):387-9. PubMed ID: 9867428
[No Abstract] [Full Text] [Related]
18. Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.
Feng S; Bucuvalas JC; Mazariegos GV; Magee JC; Sanchez-Fueyo A; Spain KM; Lesniak A; Kanaparthi S; Perito E; Venkat VL; Burrell BE; Alonso EM; Bridges ND; Doo E; Gupta NA; Himes RW; Ikle D; Jackson AM; Lobritto SJ; Jose Lozano J; Martinez M; Ng VL; Rand EB; Sherker AH; Sundaram SS; Turmelle YP; Wood-Trageser M; Demetris AJ
Hepatology; 2021 May; 73(5):1985-2004. PubMed ID: 32786149
[TBL] [Abstract][Full Text] [Related]
19. Minimization or withdrawal of immunosuppressants in pediatric liver transplant recipients.
Lin NC; Wang HK; Yeh YC; Liu CP; Loong CC; Tsai HL; Chen CY; Chin T; Liu C
J Pediatr Surg; 2015 Dec; 50(12):2128-33. PubMed ID: 26377868
[TBL] [Abstract][Full Text] [Related]
20. Tolerance after liver transplantation: Where are we?
Feng S; Bucuvalas J
Liver Transpl; 2017 Dec; 23(12):1601-1614. PubMed ID: 28834221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
